BUSINESS BRIEF

Established in 2010, the company is a manufacturer and supplier of Bulk Drug Intermediates, Fine Chemicals, Metal Reagents, Borane Reagents, and Grignard Reagents. Operating from Southern India, it serves both domestic and international markets, catering to major API and formulation companies.

  • Maximum Output: 20,100 kg/day (weight-based production capacity)
  • Installed Capacity: 166.3 KL (equipment and storage capacity)
  • Expansion Potential: 90-100 KL of available space, allowing expansion up to 256.3 KL.

Certifications:

  • DCA
  • GMP DCA
  • WHO GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • ISO 45001:2018

Manufacturing facility:

  • Total Land Area: 6.2 acres (24,902 sq. meters)
  • Built-up Area: 14,127 sq. meters

Team:

  • Production: 59
  • R&D: 30
  • Quality Control: 22
  • Engineering: 10
  • Others (Warehouse, QA, HR, Finance, and EHS): 21

Strategic Advancements:

  • Established a new manufacturing unit to focus on high-quality Active Pharmaceutical Ingredients (APIs) and their intermediates.
  • Established State-of-the-Art R&D Center dedicated to new API development and contract research collaborations with leading global companies

Products & Services

  1. APIs & Intermediates
  2. Bulk Drug Intermediates
  3. Fine Chemicals
  4. Metal Reagents
  5. Borane Reagents
  6. Grignard Reagents – Aromatic, Aliphatic and Turbo
Proposal
Icon

Industry

Pharmaceuticals

Icon

Sub Industry

Bulk Drug & API manufacturing

Icon

Nature of Business

B2B

Icon

Sector

Manufacturing (Contract Manufacturing)

Icon

Reason for sell-off

Strategic Realignment or Pursuing New Opportunities

Icon

Location

India

Icon

Region

Southern

Icon

Open For Dilution

100 % (Complete Buyout)

Icon

Top Customer

Icon

Deal Size

INR 110 - 250 Cr

Icon

Justification

Based on Market multiples

Business Operation Information
Financial Information
2024 (in INR Cr) 2023 (in INR Cr) 2022 (in INR Cr)
Sales
83.59 68.91 63.19
EBITDA
PAT
Business Documents